Targeted therapies aim to specifically target molecular abnormalities in cancer cells. Unlike traditional chemotherapy, which affects both cancerous and normal cells, targeted therapies are designed to interact with specific proteins or pathways essential for cancer cell survival and proliferation. Examples include tyrosine kinase inhibitors and monoclonal antibodies.
